![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Pharmacokinetic Interaction Between HCV Inhibitors Grazoprevir/Elbasvir With Famotidine and Pantoprazole
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Hwa-ping Feng1; Patrice Auger2; Pavan Vaddady1; Zifang Guo1; Fang Liu1; Deborah Panebianco1; Chun Feng2; Nadia Cardillo Marricco2; Vanessa Levine1; Luzelena Caro1; David Goblot2; Michael Gartner2; Daria Stypinski2; Joan R. Butterton1; Marian Iwamoto1; Wendy W. Yeh1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA
![AASLD1.gif](../../2016/images/012016/012016-1/AASLD1.gif)
![AASLD2.gif](../../2016/images/012016/012016-1/AASLD2.gif)
![AASLD3.gif](../../2016/images/012016/012016-1/AASLD3.gif)
![AASLD4.gif](../../2016/images/012016/012016-1/AASLD4.gif)
![AASLD5.gif](../../2016/images/012016/012016-1/AASLD5.gif)
![AASLD6.gif](../../2016/images/012016/012016-1/AASLD6.gif)
![AASLD7.gif](../../2016/images/012016/012016-1/AASLD7.gif)
![AASLD8.gif](../../2016/images/012016/012016-1/AASLD8.gif)
![AASLD9.gif](../../2016/images/012016/012016-1/AASLD9.gif)
![AASLD10.gif](../../2016/images/012016/012016-1/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|